In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
Impax Laboratories CEO G. Frederick Wilkinson steps down amid a Department of Justice generic price-fixing investigation. J. Kevin Buchi, who joined the board last month, was tapped as interim CEO.
Shares of leading generics fall as more charges are expected.
Companies that marked turnarounds -- for better or worse -- last week.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.